PE Ratio
43.95
₹93.55 -4.45 (-4.54%)
As on September 4, 2026
-44.64%
1 Y CAGR
158
CR
Market Cap
Company profile
Nephro Care India Ltd. operates within the healthcare sector, primarily dedicating its services to the treatment and management of renal conditions. This enterprise was founded by Pratim Sengupta on July 8, 2014, and maintains its corporate headquarters in Kolkata, India.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.16
Dividend Yield
0.00%
Sector PE
42.60
Sector ROE
11.70%
Sector Dividend Yield
0.46%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹0.9KCAGR 5-Year
+125.62%Peers & Comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
Market cap: ₹4,41,477.63 Cr
DIVISLAB
Divi's Laboratories Ltd
Market cap: ₹2,41,576.41 Cr
TORNTPHARM
Torrent Pharmaceuticals Ltd
Market cap: ₹1,82,576.57 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
